{
    "2019-05-21": [
        [
            {
                "time": "2019-05-21",
                "original_text": "格隆汇港股聚焦(5.21)︱石药一季度纯利增近三成 研发投入4.61亿元",
                "features": {
                    "keywords": [
                        "石药",
                        "一季度",
                        "纯利",
                        "研发投入"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-05-21",
                "original_text": "科创板系列之一：科创板创新药估值探讨【西南医药朱国广陈铁林团队】",
                "features": {
                    "keywords": [
                        "科创板",
                        "创新药",
                        "估值"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-05-21",
                "original_text": "5月21日上市公司晚间公告速递",
                "features": {
                    "keywords": [
                        "公告",
                        "上市公司"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-05-21",
                "original_text": "复星医药(02196.HK)：利妥昔单抗注射液获药品注册补充申请受理",
                "features": {
                    "keywords": [
                        "复星医药",
                        "利妥昔单抗",
                        "药品注册"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-05-21",
                "original_text": "复星医药：控股子公司获药品注册补充申请受理",
                "features": {
                    "keywords": [
                        "复星医药",
                        "控股子公司",
                        "药品注册"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-05-21",
                "original_text": "创新药板块拉升 冠昊生物冲击涨停",
                "features": {
                    "keywords": [
                        "创新药",
                        "冠昊生物",
                        "涨停"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-05-21",
                "original_text": "21日公司新闻聚焦：多只华为概念股提示风险",
                "features": {
                    "keywords": [
                        "华为",
                        "概念股",
                        "风险"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-05-21",
                "original_text": "华创事件驱动早报5-21：食品安全工作受高度重视；电解液价格上涨在即",
                "features": {
                    "keywords": [
                        "食品安全",
                        "电解液",
                        "价格上涨"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "食品",
                        "化工"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-05-21",
                "original_text": "细分行业分化较大 关注三大主线",
                "features": {
                    "keywords": [
                        "细分行业",
                        "分化",
                        "主线"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-05-21",
                "original_text": "云南白药盈利能力承压 陈发树迎新考验",
                "features": {
                    "keywords": [
                        "云南白药",
                        "盈利能力",
                        "陈发树"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}